Back

MET Stock

Live symbol workspace

MET market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $76.97
Trend Flat
Sentiment Neutral

Price Chart

📈
Loading chart for MET...
Powered by TradingView
{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support
$73.12
Resistance
$80.82

Volume & Momentum

Volume
Normal
1.0x avg
Momentum
0%
Weak

Technical Context

Current price
$76.97
RSI context
50

Market Sentiment

50
Neutral

Stock Metrics

Daily Vol
0%
VIX Est
20
Weekly
0%

Asset Intelligence Dossier

Over the last 30 days, AI sentiment for MET skewed neutral (12 of 18 scored calls).

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

30%
▼ 7.6 pts vs previous week
Avg confidence across 12 calls in the last 7 days

What sources say

Neutral 12 articles
The No. 1 Holding in Warren Buffett's $786 Million "Secret" Portfolio Is a Bona Fide Millionaire-Maker (but There's a Catch)
3 Reasons MET is Risky and 1 Stock to Buy Instead
Canada and India Push for Major Free Trade Deal Focused on Energy and Tech
Bullish 4 articles
U.S. Crude Exports Surge To All-Time Highs Amid SPR Releases
Boeing CEO says company met requirements to increase 737 Max production to 47 jets per month
Chinese Stocks Fall as Markets Await Signals From Xi-Trump Talks
Bearish 2 articles
Secretive Azerbaijan Deal Raises Energy Security Concerns in Georgia
Walmart Stock Falls As Dow Giant Guides Low Amid High Gas Prices

Insider Trading

Refreshing insider trades from FinViz…

Technical Observations

Refreshing technical observations from FinViz...

MET News Intelligence (35 articles)

AI-curated news influencing MET price, sentiment, and trend

Explore All MET News with AI Analysis
Stocks
1 month, 1 week ago

Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial

Intellia Therapeutics said its Crispr-based treatment for hereditary angioedema met its goals in a Phase 3 trial, marking a milestone …

Impact on MET: Neutral market sentiment indicated
FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence. High (94%)
View full analysis →
Economy
1 month, 2 weeks ago

3 Insurance Stocks We Think Twice About

Insurance companies serve as the backbone of risk management, providing essential protection and financial security for individuals and businesses. But …

Impact on MET: The insurance sector's underperformance may lead to a decrease in stock prices …
The insurance sector has underperformed the S&P 500 over the past six months, with a … Medium (60%)
View full analysis →
Stocks
4 months, 4 weeks ago

Why Howmet Stock Could Ride This Sector's Big Boost

Howmet Aerospace is emerging as a key defense stock play from 2025 that could still have currency in 2026. In …

Impact on MET: Market impact analysis based on bullish sentiment with 90% confidence.
Howmet Aerospace stock is expected to benefit from the defense sector's growth, following its acquisition … High (90%)
View full analysis →
🤖

AI Analysis

Multi-Provider AI Analysis

Neutral

AI Summary

Loading...

Confidence
0%
AI Model Multi-Provider AI Analysis